Medical Biochemoinformatics
May 8, 2010 by Bioinformatics Computational Biology · Leave a Comment
Product Description
This book summarises and presents the topics specifically relating to biochemoinformatics. Due to the advancement in “omics” science in the present day, several biochemoinformatics techniques are launched and those techniques can be applied in medicine. The summative on important topics of biochemoinformatics can be and should be performed.
Order from Amazon Today Medical Biochemoinformatics
Chemoinformatics: Theory, Practice, Products
April 24, 2010 by Bioinformatics Computational Biology · Leave a Comment
Product Description
Chemoinformatics: Theory, Practice & Products covers theory, commercially available packages and applications of Chemoinformatics. Chemoinformatics is broadly defined as the use of information technology to assist in the acquisition, analysis and management of data and information relating to chemical compounds and their properties. This ranges from molecular modelling, to reactions, to spectra, to structure-activity relationships associated with chemicals. Computational scientists, chemists, and biologists all rely on the rapidly evolving field of Chemoinformatics. Chemoinformatics: Theory, Practice & Products is an essential handbook for determining the right Chemoinformatics method or technology to use. There has been an explosion of new Chemoinformatics tools and techniques. Each technique has its own utility, scope, and limitations, as well as meeting resistance to use by experimentalists. The purpose of Chemoinformatics: Theory, Practice & Products is to provide computational scientists, medicinal chemists and biologists with unique practical information and the underlying theories relating to modern Chemoinformatics and related drug discovery informatics technologies.
The book also provides a summary of currently available, state-of-the-art, commercial Chemoinformatics products, with a specific focus on databases, toolkits, and modelling technologies designed for drug discovery. It will be broadly useful as a reference text for experimentalists wishing to rapidly navigate the expanding field, as well as the more expert computational scientists wishing to stay up to date.
It is primarily intended for applied researchers from the chemical and pharmaceutical industry, academic investigators, and graduate students.
Order from Amazon Today Chemoinformatics: Theory, Practice, & Products
Call for Applications: Young Scientists Can Receive a Scholarship for Outstanding Contributions to Chemoinformatics
February 21, 2010 by Bioinformatics Computational Biology · Leave a Comment
Call for Applications: Young Scientists Can Receive a Scholarship for Outstanding Contributions to Chemoinformatics
Berlin / Alameda, CA – Graduate and postdoctoral students are invited to apply for the “2010 FIZ CHEMIE-CINF Scholarship for Scientific Excellence” until March 28, 2010. The scholarship program of the Division of Chemical Information (CINF) of the American Chemical Society (ACS) funded by FIZ CHEMIE honors innovative ideas of the next generation of international researchers.
Read more on B.I.T.online
NOESIS TO BUILD UPON OPENEYE’S CHEMINFORMATICS TOOLKIT OECHEM
October 27, 2009 by Bioinformatics Computational Biology · Leave a Comment
OpenEye Scientific Software, Inc., the developer of innovative molecular modeling and cheminformatics solutions for drug discovery research, and Noesis ChemoInformatics Ltd, a new developer of lead discovery software emphasizing knowledge extraction and management, today announced they entered into an agreement to allow the incorporation of OpenEye’s OEChem into Noesis’ NSISToolkit.
OEChem, OpenEye’s programming library for chemistry and cheminformatics, will provide functionalities including SMILES parsing, SMARTS compiling, and substructure searching within NSISToolkit, the flagship product from Noesis that supports compound selection, molecular library and de novo design. “We are very pleased that OEChem’s speed, flexibility and robustness were among the key factors in Noesis’ decision to use our cheminformatics library within its NSISToolkit,” said Dr. Matthew Stahl, Senior Vice President of OpenEye Scientific Software, Inc. “Most of OpenEye’s technologies are made available as toolkits to enable the kind of custom solutions that Noesis creates.” He concluded, “OpenEye remains committed to providing scientifically rigorous toolkits to both end users and third party developers and we look forward to seeing the success of the new Noesis lead discovery tools.”
Christos Nicolaou, Chief Scientific Officer and Founder of Noesis, continued: “NSISToolkit provides applications that aid in the identification and optimization of lead compounds through pharmaceutical knowledge extraction, reuse and management. Such high end applications make use of several fundamental cheminformatics functionalities including substructure mining, compound clustering and chemical scaffold extraction which, in turn, need quick, robust and accurate substructure searching capabilities and general molecular manipulation. The incorporation of OEChem allows NSISToolkit to expand its offerings and provide improved performance to match its users’ needs and expectations.”
About OpenEye
OpenEye Scientific Software Inc. is a privately held company headquartered in Santa Fe, New Mexico, with offices in Boston, Massachusetts and Strasbourg, France. It was founded in 1997 to develop large-scale modeling applications and toolkits. Primarily geared towards drug discovery and design, areas of application include chemical informatics, structure generation, docking, shape comparison, charge & electrostatics and visualization. The software is designed for scientific rigor, as well as speed, scalability and platform independence. OpenEye makes most of its technology available as toolkits – programming libraries suitable for custom development. OpenEye software typically is distributable across multiple processors, supports 64-bit processing, and runs on Linux, Windows and Mac OS X, as well as HP, IBM, SGI and SUN flavors of UNIX. For further information on the company and its products, see www.eyesopen.com.
About Noesis
CNI Noesis Chemoinformatics Ltd is a new research informatics company active in the chemoinformatics and general life sciences fields. The company has extensive experience in the R&D of algorithms and computational systems that support human experts in their decision making process. Noesis technology combines knowledge discovery and management techniques with expertise in biological and chemical data and processes to develop efficient chemoinformatics solutions. Its flagship product, NSISToolkit, addresses fundamental needs of the drug development industry, namely compound selection, lead identification and optimization as well as knowledge management and reuse. The company was founded in 2006 in Nicosia, Cyprus. For more information please see www.noesisinformatics.com.
GVK Biosciences (GVK BIO) along with Wyeth Research won the prestigious European Outsourcing Award 2009
October 27, 2009 by Bioinformatics Computational Biology · Leave a Comment
GVK Biosciences (GVK BIO) along with Wyeth Research won the prestigious European Outsourcing Award 2009 for the Best New Partnership. The award was received by Manni Kantipudi, President, GVK BIO at a ceremony held at the Intercontinental Grand, Madrid, on 14th October. GVK BIO-Wyeth came out as winners amongst several competing entries.
Earlier in the year, GVK BIO had filed its nominations under two categories “Best New Product” and the “Best New Partnership/Acquisition/Merger”. GVK BIO’s entry for the “Best New Product” was its innovative “Clinical Biomarker Database” developed together with a Big Pharma and the US FDA. “GVK BIO – Wyeth: Value co-creators” was GVK BIO’s nomination for the “Best New Partnership”. GVK BIO were declared finalists in both categories.
“We are delighted to have won the Best New Partnership Award along with our partner, Wyeth Research. This award is recognition of the dedication and commitment of our employees in understanding and delivering to our customers’ expectations. We are proud that we have been considered alongside with Wyeth and thank them for their faith and commitment to this collaboration” said Manni Kantipudi, President, GVK Biosciences.
The nomination for the Best New Partnership was put together by GVK BIO and Wyeth. It covered the GVK BIO-Wyeth trendsetting deal of 150 synthetic chemistry deal in 2006, further expansion of the collaboration to chemoinformatics and modeling. In 2008, Wyeth and GVK BIO entered into a collaboration based on a risk sharing model to identify and optimize lead series.
About European Outsourcing Awards
Launched in 2005, The European Outsourcing Awards recognize new and significant developments in Contract Services and reward successful companies for their outstanding contributions throughout the year. The Awards recognize excellence in R&D, marketing, business and technology across the pharmaceutical outsourcing, biopharmaceutical and clinical trial industries. The awards function is alongside the annual CPhI/ICSE/PMEC .
About GVK BIO
GVK Biosciences (GVK BIO) is Asia’s leading research services organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. GVK BIO’s diverse portfolio of more than 100 customers includes Big Pharma companies, Agri & Life-sciences companies, leading biotechs and academic institutions. Spread across five locations in India, GVK BIO is headquartered at Hyderabad, India and employs 1500+ people to assist clients accelerate their research and success.
